Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1983-12-12
1986-12-30
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 424 85, 2603975, 26039745, 514182, A61K 4900, A61K 4300
Patent
active
046328203
ABSTRACT:
Novel radioactive .DELTA..sup.4,9,11 -estratrienes marked with iodine 125 or 131 having the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 2 to 12 carbon atoms, R.sub.1 is the reminder of an amino acid of the formula R.sub.1 NH.sub.2 or a derivative thereof being marked with iodine 125 or 131 and the wavy lines indicate the --OR is in the .alpha.- or .beta.-position and the oximido group is in the syn or anti position, a process and intermediates for their preparation, antigens prepared therefrom and use thereof to prepare antibodies.
REFERENCES:
patent: 4323511 (1982-04-01), Varma et al.
patent: 4331646 (1982-05-01), Delaage
"Steroids" (1978) vol. 31, No. 3, pp. 393-406, article by Scott et al.
Jouquey Alain
Mouren Michel
Salmon Jean
Touyer Gaetan
Roberts Elbert L.
Roussel Uclaf
LandOfFree
Novel radioactive estratrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel radioactive estratrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel radioactive estratrienes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1546667